P51 / Research station
Compound research profile

MOTS-c Research: Mitochondrial Signaling & Study Models

Explore the original MOTS-c publication, mitochondrial peptide signaling, and how to distinguish experimental metabolic findings from human outcomes.

What is MOTS-c?

The 2015 primary publication describes MOTS-c as a 16-amino-acid peptide encoded within mitochondrial 12S rRNA. It introduced a research framework in which a mitochondrial-derived peptide participates in metabolic signaling.

What was studied?

The original work used cellular and animal experiments to investigate metabolic homeostasis and insulin-sensitivity-related biology. Its findings are model-specific observations, not a clinical evaluation of a commercially supplied research material.

A second mechanistic question

A 2018 study examined movement of MOTS-c to the nucleus and regulation of gene expression during metabolic stress. This adds a mechanistic layer to the literature; it does not make a cellular mechanism equivalent to an established clinical outcome.

How to compare studies

Separate endogenous peptide measurements, cell experiments, animal interventions and human studies. Note what was measured and how the investigators characterized the material. Similar topic labels can conceal very different experimental questions.

Sources & further reading

  1. Lee et al., 2015 — original MOTS-c study
  2. Kim et al., 2018 — nuclear translocation study
This overview explains research context and evidence limits. It is not a systematic review or medical guidance. No availability, product quality, or equivalence to study materials is implied. Follow the original source for methods and limitations.

Continue reading

Explore all research guides →

Browse the compound directory →

P51 / Evidence tracker

FDA approval & clinical-trial status

Sources checked 2026-10-10 (UTC). Status describes registry records and named drug products.

FDA / United States

No FDA approval record located

The checked Drugs@FDA ingredient searches did not locate an approval record. This is a database search result, not an exhaustive regulatory determination; compounding eligibility is a separate question.

    FDA database and coverage ↗
    ClinicalTrials.gov

    Active study records reported

    1 active · 0 planned · 0 completed · 1 matching records

    Counts include matching drug or biological interventions in ClinicalTrials.gov. Biomarker-only studies and related compounds are excluded. Registration and a reported phase do not establish safety, efficacy, FDA approval, or that a trial is taking place as described. Check each record and its update date.

    Search the trial registry ↗
    View matching trial records (1)
    Publication archive

    Articles associated with MOTS-c

    Indexed publications mentioning this compound in their title or abstract, newest first. Follow the original papers for findings and limitations; preprints are labeled.

    Open full source search ↗

    266 indexed matches. Sources checked 2026-10-10 (UTC).

    Search coverage is limited to Europe PMC. Related names, formulations, and study models may differ from listed research materials. A paper mentioning a compound is not necessarily a clinical trial or evidence of effectiveness.